CBU
TERN

CIBC Bancorp USA’s Terns Pharmaceuticals TERN Stock Holding History

CIBC Bancorp USA’s Portfolio TERN Stock Details TERN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-9,820
Closed -$518K – 2032
2026
Q1 		$518K Buy
+9,820
New +$403K ﹤0.01% 1223

Other funds holding TERN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

CIBC Bancorp USA's TERN Position: Q2 2026 in Review

CIBC Bancorp USA sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 9,820 shares — an estimated $518K sold.

CIBC Bancorp USA first reported a position in TERN in Q1 2026 and held it in 1 quarter. The position peaked at $518K in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

  • CIBC Bancorp USA reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • CIBC Bancorp USA sold 9,820 Terns Pharmaceuticals shares in Q2 2026, an estimated $518K.
  • CIBC Bancorp USA first reported a position in Terns Pharmaceuticals in Q1 2026 and held it in 1 quarter.
  • CIBC Bancorp USA's Terns Pharmaceuticals position peaked at $518K in Q1 2026.
  • 1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on CIBC Bancorp USA's 13F filing for Q2 2026, filed 13 Aug 2026.